These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18223232)

  • 21. Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity.
    Nallar SC; Kalakonda S; Sun P; Ohmori Y; Hiroi M; Mori K; Lindner DJ; Kalvakolanu DV
    Am J Pathol; 2010 Aug; 177(2):896-907. PubMed ID: 20595633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Cao F; Zhang Q; Chen W; Zheng F; Ran Q; He Y; Gao Y; Yao S
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29074558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GRIM-19 inhibition induced autophagy through activation of ERK and HIF-1α not STAT3 in Hela cells.
    Yue X; Zhao P; Wu K; Huang J; Zhang W; Wu Y; Liang X; He X
    Tumour Biol; 2016 Jul; 37(7):9789-96. PubMed ID: 26810068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GRIM-19 over-expression represses the proliferation and invasion of orthotopically implanted hepatocarcinoma tumors associated with downregulation of Stat3 signaling.
    Kong D; Chen J; Sun X; Lin Y; Du Y; Huang D; Cheng H; He P; Yang L; Wu S; Zhao L; Meng X
    Biosci Trends; 2019; 13(4):342-350. PubMed ID: 31527330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GRIM‑19‑mediated Stat3 activation is a determinant for resveratrol‑induced proliferation and cytotoxicity in cervical tumor‑derived cell lines.
    Li YG; Xia HJ; Tao JP; Xin P; Liu MY; Li JB; Zhu W; Wei M
    Mol Med Rep; 2015 Feb; 11(2):1272-7. PubMed ID: 25351437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GRIM-19 repressed hypoxia-induced invasion and EMT of colorectal cancer by repressing autophagy through inactivation of STAT3/HIF-1α signaling axis.
    Zhang J; Chu D; Kawamura T; Tanaka K; He S
    J Cell Physiol; 2019 Aug; 234(8):12800-12808. PubMed ID: 30537081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
    Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
    Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma].
    Gong LB; Luo XL; Liu SY; Tao DD; Gong JP; Hu JB
    Ai Zheng; 2007 Jul; 26(7):683-7. PubMed ID: 17626740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Glucose Induces Down-Regulated GRIM-19 Expression to Activate STAT3 Signaling and Promote Cell Proliferation in Cell Culture.
    Li YG; Han BB; Li F; Yu JW; Dong ZF; Niu GM; Qing YW; Li JB; Wei M; Zhu W
    PLoS One; 2016; 11(4):e0153659. PubMed ID: 27101310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GRIM-19 in Health and Disease.
    Máximo V; Lima J; Soares P; Silva A; Bento I; Sobrinho-Simões M
    Adv Anat Pathol; 2008 Jan; 15(1):46-53. PubMed ID: 18156812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GRIM-19 opposes reprogramming of glioblastoma cell metabolism via HIF1α destabilization.
    Liu Q; Wang L; Wang Z; Yang Y; Tian J; Liu G; Guan D; Cao X; Zhang Y; Hao A
    Carcinogenesis; 2013 Aug; 34(8):1728-36. PubMed ID: 23580587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth.
    Okamoto T; Inozume T; Mitsui H; Kanzaki M; Harada K; Shibagaki N; Shimada S
    Mol Cancer Ther; 2010 Aug; 9(8):2333-43. PubMed ID: 20682646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.
    Liu R; Sun J; Zhang Z; Xu Y
    Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of GRIM-19 accelerates radiation-induced osteosarcoma cells apoptosis by p53 stabilization.
    Chen W; Liu Q; Fu B; Liu K; Jiang W
    Life Sci; 2018 Sep; 208():232-238. PubMed ID: 30005830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
    Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
    J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism.
    Nallar SC; Kalvakolanu DV
    Cytokine Growth Factor Rev; 2017 Feb; 33():1-18. PubMed ID: 27659873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment.
    Li X; Li Y; Wang B; Ji K; Liang Z; Guo B; Hu J; Yin D; Du Y; Kopecko DJ; Kalvakolanu DV; Zhao X; Xu D; Zhang L
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):971-80. PubMed ID: 23463096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer.
    Lee JH; Kim C; Baek SH; Ko JH; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
    Oncotarget; 2017 Mar; 8(11):17700-17711. PubMed ID: 27458171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.